Shigellosis Vaccine
Shigella flexneri 2a vaccine protects against shigellosis symptoms
Published in Vaccine Weekly, April 28th, 2004
According to recent research from the United States, "We report the first community-based evaluation of Shigella flexneri 2a strain SC602, a live, oral vaccine strain attenuated by deletion of the icsA (virG) plasmid virulence gene, given at 104 CFU. The primary objectives of this trial were to determine the safety and immunogenicity of the vaccine and to determine the duration of colonization. Four of 34 volunteers experienced transient fevers, and three reported diarrhea during the first three days of the study."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-04-28)
More Articles from Vaccine Weekly
- Influenza Vaccine
Influenza vaccination changes lymphocyte distribution in tonsils - Malaria Vaccine
Antibodies to malaria peptide mimics inhibit invasion of erythrocytes - Meningococcal Vaccine
Mimics of capsular polysaccharide protect against group B meningococci - Tuberculosis Vaccine
Mycobacterium bovis BCG plus novel adjuvant protects against tuberculosis - AIDS/HIV Vaccine
Finding epitopes of HIV-1 that induce protective antibodies remains a challenge - AIDS/HIV Vaccine
MVA-HIV-1 nef vaccine elicits T-helper cell responses in HIV patients - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
